Pharmyn ApS: Financial statements 2023
CVR: 37133892
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 10,454 and a net result of DKK 10,429 compared with DKK -19,953 the year before. Equity in the 2023 report amounted to DKK 24,370. The solvency ratio was 83.9%.
- Gross Profit
- DKK 10,454
- Profit/Loss
- DKK 10,429
- Equity
- DKK 24,370
- Total Assets
- DKK 29,057
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 10 t. | 10 t. | 24 t. | 0 |
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
| 2019 | - | 108 | 0 | 42 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmyn ApS has published its annual report for 2022. Gross profit came to DKK -19,740, and the net result was DKK -19,953.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.